Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
4.005
+0.495 (14.10%)
Jan 5, 2026, 2:05 PM EST - Market open
Altimmune Employees
Altimmune had 59 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
59
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$339
Profits / Employee
-$1,422,288
Market Cap
437.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 59 | 0 | - |
| Dec 31, 2023 | 59 | 7 | 13.46% |
| Dec 31, 2022 | 52 | 5 | 10.64% |
| Dec 31, 2021 | 47 | 4 | 9.30% |
| Dec 31, 2020 | 43 | 18 | 72.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ALT News
- 6 hours ago - Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH - GlobeNewsWire
- 12 days ago - Altimmune: Pemvidutide's 48-Week Data Confirms The Market's Smokescreen - Seeking Alpha
- 17 days ago - Altimmune's MASH Drug Shows Durable Liver, Weight Loss Gains At 48 Weeks - Benzinga
- 17 days ago - Altimmune, Inc. (ALT) Discusses Topline 48-Week Results From IMPACT Phase IIb Trial of Pemvidutide in MASH Transcript - Seeking Alpha
- 17 days ago - Altimmune's drug for a type of liver disease shows benefits in mid-stage study - Reuters
- 17 days ago - Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial - GlobeNewsWire
- 5 weeks ago - Altimmune Announces CEO Transition and Succession Plan - GlobeNewsWire
- 5 weeks ago - Altimmune to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire